Die Behandlung der Endometriose mit einem langwirksamen, injizierbaren LH-RH-Analogon (Buserelin)

Inka Wiegratz, M. Dannhof, R. Baumann, H.‐D. Taubert
In: Archives of Gynecology and Obstetrics · 1993 · vol. 254(1-4) , pp. 592–594 · doi:10.1007/bf02266112 · W4242431297
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06+body, 2026-06-12 ⓘ

This study evaluated the treatment of endometriosis using a long-acting, injectable LHRH analogue, Buserelin.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-10 · read from full text ⓘ

The paper by Wiegratz and colleagues (1993) discusses the treatment of endometriosis using a long-acting, injectable LH-RH (GnRH) analog, buserelin. It is presented as a brief clinical-focused report in which buserelin is used to suppress ovarian function, with the goal of improving endometriosis-related outcomes. The explicit limitation noted in the available text is that the excerpt contains no detailed methods, patient population, or outcome data, since only bibliographic and contextual information is provided here. This paper is centrally about endometriosis—specifically the treatment of endometriosis with long-acting injectable buserelin.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,184 characters · extracted from oa-doi-fallback · click to expand
Literatur Barbieri, R.L.: Etiology and epidemiology of endometriosis Am. J. Obstet. Gynecol. 162, 565–567, 1990 Buttram, V.C. jr.: Evolution of the Revised American Fertility Society Classification of Endometriosis Fertil Steril 43, 347–350, 1985 Evers, J.L.H.: The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression Fertil Steril 47, 502–504, 1987 Brown, J.B.: Gonadotropins In: Infertility. Male and Female, p. 359, Insler, V., Lunenfeld, B. (eds.) Edinburgh, Churchill Livindston 1986 Fraser, H.M., Sandow, J., Seidel, H., v.Rechenberg, W.: An implant of agonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3–5 month Acta Endocrinol (Copenh) 115, 521–527, 1987 Author information Authors and Affiliations Rights and permissions About this article Cite this article Wiegratz, I., Dannhof, M., Baumann, R. et al. Die Behandlung der Endometriose mit einem langwirksamen, injizierbaren LH-RH-Analogon (Buserelin). Arch Gynecol Obstet 254, 592–594 (1993). https://doi.org/10.1007/BF02266112 Issue date: DOI: https://doi.org/10.1007/BF02266112

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

die_deep_infiltrating

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK